A model of survivorship in cancer genetic care

Seminars in Oncology Nursing

Volumn 20, Issue 3, 2004, Pages 196-202

  Jacobs, Linda A ^a   Giarelli, Ellen ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BREAST CANCER; BREAST EXAMINATION; CANCER EPIDEMIOLOGY; CANCER GENETICS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SCREENING; CANCER SURVIVAL; ECHOMAMMOGRAPHY; FAMILIAL CANCER; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HUMAN; MAMMOGRAPHY; MASTECTOMY; MULTIPLE ENDOCRINE NEOPLASIA; NECK DISSECTION; ONCOGENE; QUALITY OF LIFE; SALPINGOOOPHORECTOMY; THYROID CANCER; THYROIDECTOMY; TREATMENT OUTCOME;

ADAPTATION, PSYCHOLOGICAL; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; NEOPLASTIC SYNDROMES, HEREDITARY; NURSE-PATIENT RELATIONS; NURSING ASSESSMENT; NURSING METHODOLOGY RESEARCH; ONCOLOGIC NURSING; PATIENT EDUCATION; QUALITY OF LIFE; RISK FACTORS; SURVIVORS;

EID: 4143081841     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.soncn.2004.04.006     Document Type: Article

References (24)

1. Grant M., Padilla G.V., Greimel E.R. Survivorship and quality of life issues. McCorkle R., Grant M., Frank-Stromborg M., Baird S.B. Cancer nursing a comprehensive textbook. Ed 2 :1996;1313-1321 Saunders, Philadelphia, PA
2. Leigh S. Defining our destiny. Hoffman B. A cancer survivor's almanac charting your journey. 1996;261-271 Chronimed Publishing, Minneapolis, MN
3. Leigh S. Preface the culture of survivorship. Semin Oncol Nurs. 17:2001;234-235
4. Marshall E. Preventing toxicity with a gene test. Science. 302:2003;588-590
5. McLeod H.L., Yu J. Cancer pharmacogenomics SNPS, chips, and the individual patient. Cancer Invest. 21:2003;630-640
6. Watters J.W., McLeod H.L. Cancer pharmacogenomics current and future applications. Biochim Biophys Acta. 1603:2003;99-111
7. Egawa C., Motomura K., Miyoshi Y., et al. Increased expression of BRCA1 mRNA predicts favorable response to anthracycline-containing chemotherapy in breast cancers. Breast Cancer Res Treat. 78:2003;45-50
8. Constant M.M.E., Menke-Pluijmers M.B.E., Seynavet C., et al. Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation. Eur J Surg Oncol. 28:2002;627-632
9. Baeyens A., Thierens H., Claes K., et al. Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition. Br J Cancer. 87:2002;1379-1385
10. Pierce L., Strawderman M., Narod S., et al. Effect of radiotherapy after breast-conserving treatment in women with breast cancers and germline BRCA1/2 mutations. J Clin Oncol. 18:2000;3360-3369
11. Sharan S.K., Morimatsu M., Albrecht U., et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking BRCA2. Nature. 386:1997;804-810
12. Bonadona V., Lasset C. Inherited predisposition to breast cancer after the BRCA1 and BRCA2 genes, what next? Bull Cancer. 90:2003;587-594
13. Sakorafas G.H., Tsiotou A.G. Genetic predisposition to breast cancer a surgical perspective. Br J Surg. 87:2000;149-162
14. Eeles R. Future possibilities in the prevention of breast cancer intervention strategies in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. 2:2000;283-290
15. Kinney A., DeVellis B., Skrzynia C., Millikan R. Genetic testing for colorectal carcinoma susceptibility. Cancer. 91:2001;57-65
16. Smith R., Saslow D., Sawyer K.A., et al. American Cancer Society guidelines for breast cancer screening update 2003. CA Cancer J Clin. 53:2003;141-169
17. Meijers-Heijboer E.J., Verhoog L.C., Brekelmans C.T.M., et al. Considerations in genetic testing and prophylactic measures. Lancet. 5:2001;117-120
18. Pellegrino E.D. Toward a reconstruction of medical morality the primacy of the act of profession and the fact of illness. J Med Philosophy. 4:1979;32-55
19. Giarelli E. Safeguarding being a bioethical principle for genetic nursing care. Nurs Ethics. 10:2003;255-268
20. Giarelli E. Bringing threat-to-the-fore participating in life-long surveillance for genetic risk of cancer. Oncol Nurs Forum. 6:2003;945-955
21. Modigliani E., Vasen H., Raue K., et al. Pheochromocytoma in multiple endocrine neoplasia type 2 European study. J Intern Med. 238:1995;363-367
22. Pausova Z., Soliman E., Amizuka N., et al. Role of the RET proto-oncogene in sporadic hyperparathyroidism and in the hyperparathyroidism of MEN type 2a. J Clin Endocrinol Metab. 81:1996;2711-2718
23. McKusick F.A. Mendelian inheritance in man a catalog of human genes and genetic disorders. Ed 12 :1997;Johns Hopkins University Press, Baltimore, MD. Available at: www.ncbi.nlm.nih/gov/htbin-post/Omim.htm (accessed Oct 7, 2003)
24. Kuhn T.S. The structure of scientific revolutions. 1962;The University of Chicago Press, Chicago, IL